Ongoing clinical trials under study involving nanomaterials for skin cancer
| Trial No. | Nanomaterial under study | Condition | Phase | Status | References |
|---|---|---|---|---|---|
| NCT00004104 | Liposome/interferon alfa-2b and melanoma vaccine | Melanoma | Phase 2 | Completed | [166] |
| NCT00081042 | Albumin-nanoparticle/paclitaxel (ABI-007) | Melanoma | Phase 2 | Completed | [167] |
| NCT00145041 | Liposome/vincristine | Melanoma | Phase 1 | Completed | [168] |
| NCT00626405 | Albumin nanoparticle/paclitaxel | Melanoma | Phase 2 | Completed | [169] |
| NCT01300533 | Nanoparticle/docetaxel (BIND-014) | Skin cancer | Phase 1 | Completed | [170] |
| NCT02158520 | Albumin nanoparticle/paclitaxel (Abraxane®) | Melanoma | Phase 2 | Completed | [171] |
| NCT03101358 | Topical nanoparticle ointment/paclitaxel (SOR007) | Cutaneous metastases from non-melanoma cancer | Phase 1 and 2 | Completed | [172] |